ARCHIVES

CMS Considering Regulatory Standards for Drug Company Bundling of Products.

This article is from The Cancer Letter archive.

Vol. 32 No. 37 | October 20, 2006

Download PDF Visit The Full Archive

Related Articles

Combined analysis moves Herceptin to adjuvant setting in breast cancer.

May 27, 2005

DCBDC Board OK’s Concepts For New Small Grant Programs

March 23, 1990

Also STAR trial can be completed with fewer women than planned, NSABP says.

November 7, 2003

Next Bypass Budget: Slim, Trim, Modest

September 15, 1995

NIH Panel finalizes Consensus Statement; Two Panelists Join In Minority Opinion

March 28, 1997

Scientists Lose Credibility When “Fire Alarm” Pulled Too Early, ACS’s Brawley Says.

August 1, 2008